News Archives - Page 2 of 781

TuesdayApr 28, 2026 9:00 am

The Evidence-Interrogation Play: How Oncotelic Therapeutics Inc.’s (OTLC) PDAOAI Platform Fits Pharma’s Broader AI Transformation

Oncotelic's PDAOAI platform indexes 125,000+ PubMed abstracts on TGF-β signaling, enabling researchers to interrogate the evidence for testable, auditable hypotheses rather than rely on black-box predictions. Recent industry coverage places Oncotelic alongside Rockwell Automation, Emerson Electric, Thermo Fisher Scientific, and Danaher as contributors to the pharmaceutical sector's shift toward AI-integrated operations. The hypothesis-first approach addresses a core challenge in biotech research: reducing training-set bias and building transparent, reproducible chains from question to evidence to hypothesis. Pharmaceutical research and manufacturing are undergoing a structural transition. Regulatory agencies are raising expectations around data integrity and traceability, while the industry is shifting from…

MondayApr 27, 2026 9:45 am

Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) Expands into Orbital Technologies as Space Infrastructure Race Accelerates

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising. Planet Ventures is increasing its exposure to AI-driven space infrastructure through strategic investment in Antaris The company is positioning itself at the intersection of orbital computing, satellite software, and the next frontier These moves underscore a broader industry shift toward space-based data infrastructure and lunar-enabling technologies Planet Ventures (CSE: PXI) (OTC: PNXPF) (FSE: P6U) is aligning itself with one of the transformative trends in modern technology: the convergence of space infrastructure and artificial intelligence. With global demand for computing power increasing and terrestrial constraints on…

MondayApr 27, 2026 9:00 am

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Advancing AI Solutions for Cardiovascular Disease Detection and Management

The scale and impact of cardiovascular disease underscore why innovation in this area is so critical. Advances in genomics and epigenetics are making it possible to better understand how genetic predisposition and environmental influences interact to drive disease progression. By utilizing a simple blood test, Cardio Diagnostics is lowering barriers to advanced cardiovascular testing. Cardiovascular disease remains one of the most serious and costly health challenges worldwide, driving an urgent need for earlier detection and more precise, personalized treatment strategies. Cardio Diagnostics Holdings (NASDAQ: CDIO) is focused on addressing this need by developing advanced solutions that leverage artificial intelligence (“AI”) and…

FridayApr 24, 2026 12:30 pm

Safe Pro Group Inc. (NASDAQ: SPAI) Reveals Its Next-Gen Miniature AI-Powered Edge Compute Processor of Drone Footage for Threat Detection

Safe Pro Group recently began the commercial rollout of NODE-X, a next-gen miniaturized AI-powered edge compute processor of drone footage for threat detection. The rollout began at a U.S. Army Exercise, and NODE-X is scheduled to be a part of additional U.S. Army exercises throughout the second quarter of 2026. NODE-X is powered by Safe Pro’s patented Safe Pro Object Threat Detection (“SPOTD”), a powerful technology used to rapidly analyze drone imagery and video to identify and detect small explosive threats. Safe Pro Group (NASDAQ: SPAI), a developer of AI-enabled security, defense, and situational awareness solutions, recently started the commercial…

FridayApr 24, 2026 11:45 am

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Atikokan Project Assay and Findings Identify Rare Earth Exploration Targets

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Integrated geochemical and geophysical data point to structurally controlled mineralization at Atikokan rare earth property. Dashwa Gneiss Complex emerges as the primary focus for follow-up work. Soil, rock, and sediment sampling indicate consistent rare earth element (“REE”) anomalies. Results support a coherent exploration model rather than isolated occurrences. The project aligns with rising strategic demand for domestic REE supply in North America. Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF), a Canadian mineral exploration company focused on rare earth projects across North America, has refined its exploration strategy…

FridayApr 24, 2026 11:00 am

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) AI Platform Brings Precision to Heart Health

At the core of Cardio Diagnostics’ approach is the use of artificial intelligence to integrate multi-omic data to provide a more comprehensive view of cardiovascular health. The company’s proprietary platform is designed to analyze a patient’s molecular profile from a single blood draw and generate actionable insights related to cardiovascular disease risk. CDIO’s focus on accessibility and scalability is also notable. Cardiovascular diagnostics are undergoing a transformation as advances in molecular science and artificial intelligence (“AI”) converge to deliver more precise, individualized insights from minimally invasive tests. Cardio Diagnostics Holdings (NASDAQ: CDIO) is at the forefront of this shift, developing a…

ThursdayApr 23, 2026 9:45 am

The Undrilled Basin Thesis: How Greenland Energy Company (NASDAQ: GLND) Is Advancing a 2 million-Acre Arctic Opportunity

Greenland Energy holds rights to up to 70% working interest across three onshore licenses covering more than 2 million acres in East Greenland's Jameson Land Basin. Independent Sproule ERCE engineering estimates indicate recoverable oil upside of 13 billion barrels across the basin, which was extensively evaluated by ARCO decades ago but never drilled. The company has contracted Stampede Drilling for Arctic-rated rig services alongside agreements with Halliburton, Desgagnés, and IPT Well Solutions to support its 2026 drilling campaign. Onshore basins of genuine scale that remain undrilled are increasingly rare. Most of the world's major hydrocarbon-producing regions have been systematically tested…

ThursdayApr 23, 2026 9:00 am

Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) Is ‘One to Watch’

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF)and may include paid advertising. Planet Ventures provides shareholders with exposure to private space and aerospace companies through a publicly traded investment vehicle. The company employs a diversified portfolio strategy spanning infrastructure, software, energy, robotics, and emerging space applications. Its investment approach is positioned to benefit from the continued growth and commercialization of the global space sector. Recent activity includes investments in Relativity Space (via MCXGP), Antaris following its $28 million Series A financing, and General Astronautics, a Y Combinator Winter 2026 company. The company has also deployed capital into…

WednesdayApr 22, 2026 10:30 am

The Private Access Thesis: How Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) Gained Exposure to Relativity Space’s Next Phase

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) and may include paid advertising. Planet Ventures Inc. recently invested USD$125,000 in MCXGP Relativity Fund I, LLC, a special purpose vehicle that participated in the latest financing round of Relativity Space Inc. Relativity Space, led by former Google CEO Eric Schmidt since 2025, is advancing the Terran R fully reusable launch vehicle while also exploring orbital data centers optimized for artificial intelligence workloads. The investment adds to Planet Ventures’ growing space sector portfolio, which previously included exposure to orbital energy infrastructure and cislunar development opportunities. The private space sector…

WednesdayApr 22, 2026 9:00 am

CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Sees 2026 to Be the Company’s Best Year Yet

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising. CMX Gold & Silver Corp., advancing the historic brownfield Clayton Silver Mine in Idaho, expects 2026 to be its most important and transformative year yet. In March, the company acknowledged promising geological indicators that further validated its commitment to advancing operations at its Clayton Silver Project. The mine’s clearly positive geology, together with the fact that it was never fully tapped or even explored, points to the property’s waiting potential. To speed progress, the company has undertaken a non-brokered private placement financing for aggregate…

Site Search

Company Search

Category: News